Hip disease in juvenile rheumatoid arthritis

Charles H Spencer1, Bram H Bernstein

  • 1Section of Rheumatology, La Rabida Children's Hospital, University of Chicago Children's Hospital, Pritzker School of Medicine, Chicago, Illinois 60649, USA. spencercharlesh@aol.com

Insights

Juvenile rheumatoid arthritis (JRA) frequently impacts hips, risking future disability. Modern treatments and surgical advances are improving outcomes for children with JRA hip disease.

Area of Science:

  • Pediatric Rheumatology
  • Orthopedic Surgery
  • Clinical Medicine

Background:

  • Hip involvement is common in severe, destructive juvenile rheumatoid arthritis (JRA), affecting 30-50% of affected children.
  • Hip disease in JRA signifies a risk of future disability due to the joint's weight-bearing role.
  • Clinicians face challenges in preventing, halting, and managing JRA-related hip disease, including surgical interventions.

Purpose of the Study:

  • To review the challenges and current trends in managing hip disease in juvenile rheumatoid arthritis (JRA).
  • To highlight the impact of evolving treatment strategies and surgical improvements on JRA hip disease outcomes.

Main Methods:

  • Review of current clinical practices and treatment trends for JRA hip disease.
  • Analysis of recent advancements in pediatric rheumatologic care and orthopedic surgery.

Main Results:

  • Aggressive treatment approaches and effective medications are reducing the incidence of severe JRA hip disease requiring surgery.
  • Improvements in hip arthroplasty techniques have led to better surgical outcomes for children with JRA.

Conclusions:

  • Early and aggressive management is crucial for mitigating hip involvement in JRA.
  • Advances in both medical and surgical fields are improving the long-term prognosis for children with JRA affecting the hips.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Development of the Limb Synovial Joints01:07

Development of the Limb Synovial Joints

Joints form during embryonic development in conjunction with the formation and growth of the associated bones. The embryonic tissue that gives rise to all bones, cartilage, and connective tissues of the body is called mesenchyme.
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...